Cell therapy stocks
Daily analysis · Oct 27, 2026
Among companies priced in the latest session, 33 fell and 13 rose, while Iovance Biotherapeutics, Inc. (IOVA) recorded a 496.5% one-year change and Chimeric Therapeutics Limited (CHM.AX) a -99% change.
- Legend Biotech Corporation (LEGN): +5.8% one day move, mid cap
- Cabaletta Bio, Inc. (CABA): −8.2% one day move, small cap
- Pluri Inc. (PLUR): +13.1% one day move, micro cap
Generated from today's data · Not investment advice
Heavily traded in Cell therapy
Turnover over $10M/day21 of about 80 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 27, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| IOVAIovance Biotherapeutics, Inc. | $172.44M | +496.54% | Reports Nov 5, 2026 |
| LEGNLegend Biotech Corporation | $40.27M | −36.52% | Nov 11, 2026 |
| VCELVericel Corporation | $21.74M | +18.01% | Reports Nov 5, 2026 |
| BLFSBioLife Solutions Inc | $29.98M | +37.70% | Reports Nov 5, 2026 |
| VORVor Biopharma Inc. | $15.10M | −34.84% | Nov 12, 2026 |
| CYRXCryoport, Inc. | $10.14M | +71.06% | Reports Nov 5, 2026 |
| IMMXImmix Biopharma, Inc. | $11.05M | +137.76% | Reports Nov 6, 2026 |
| 4592.TSanBio Company Limited | $643.66M | −66.98% | Dec 15, 2026 |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
79 companies, largest market value first.
Data as of Oct 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics, Inc. | $6.24B | Mid cap | +496.54% |
| LEGN | Legend Biotech Corporation | $3.97B | Mid cap | −36.52% |
| VCEL | Vericel Corporation | $2.18B | Mid cap | +18.01% |
| BLFS | BioLife Solutions Inc | $1.89B | Small cap | +37.70% |
| MSB.AX | Mesoblast Limited | $1.63B | Small cap | −30.27% |
| MESO | Mesoblast Limited | $1.61B | Small cap | −25.85% |
| VOR | Vor Biopharma Inc. | $993.23M | Small cap | −34.84% |
| CYRX | Cryoport, Inc. | $901.05M | Small cap | +71.06% |
| SANA | Sana Biotechnology, Inc. | $706.49M | Small cap | −55.05% |
| IMMX | Immix Biopharma, Inc. | $668.20M | Small cap | +137.76% |
| PROK | ProKidney Corp. | $542.89M | Small cap | −57.76% |
| 4592.T | SanBio Company Limited | $445.86M | Small cap | −66.98% |
| 005690.KS | Pharmicell Co., Ltd. | $434.35M | Small cap | −39.35% |
| ALLO | Allogene Therapeutics, Inc. | $418.04M | Small cap | −1.63% |
| AUTL | Autolus Therapeutics plc | $407.23M | Small cap | −7.27% |
| 219A.T | Heartseed Inc. | $392.80M | Small cap | +47.22% |
| 4894.T | Cuorips Inc. | $365.69M | Small cap | +1.25% |
| CAPR | Capricor Therapeutics, Inc. | $333.72M | Small cap | −7.12% |
| KYTX | Kyverna Therapeutics, Inc. | $325.91M | Small cap | −32.52% |
| ARTV | Artiva Biotherapeutics, Inc. | $301.16M | Small cap | +22.22% |
| IPSC | Century Therapeutics, Inc. | $257.13M | Small cap | +136.67% |
| LCTX | Lineage Cell Therapeutics, Inc. | $252.12M | Small cap | −43.03% |
| FATE | Fate Therapeutics, Inc. | $246.23M | Small cap | +32.58% |
| 4593.T | Healios K.K. | $231.34M | Small cap | −45.19% |
| CABA | Cabaletta Bio, Inc. | $228.89M | Small cap | −51.61% |
| LYEL | Lyell Immunopharma, Inc. | $228.14M | Small cap | −45.97% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | $189.61M | Small cap | +48.48% |
| RNAC | Cartesian Therapeutics, Inc. | $186.98M | Small cap | −29.04% |
| MXCT | MaxCyte, Inc. | $155.84M | Small cap | −1.95% |
| 504A.T | Innovacell Inc. | $132.96M | Small cap | −55.43% |
| NKTX | Nkarta, Inc. | $131.07M | Small cap | −22.13% |
| TVGN | Tevogen Inc. | $98.35M | Micro cap | −80.10% |
| CLLS | Cellectis S.A. | $97.36M | Micro cap | −73.37% |
| OCC.AX | Orthocell Limited | $94.65M | Micro cap | −57.14% |
| ATRA | Atara Biotherapeutics, Inc. | $83.81M | Micro cap | −46.44% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | $56.40M | Micro cap | −30.50% |
| ALPS | Alps Group Inc | $54.51M | Micro cap | −87.20% |
| INKT | MiNK Therapeutics, Inc. | $53.22M | Micro cap | −28.27% |
| 4896.T | K Pharma,Inc. | $51.41M | Micro cap | +4.29% |
| 7776.T | CellSeed Inc. | $47.54M | Micro cap | −57.24% |
| 4584.T | Kidswell Bio Corporation | $47.17M | Micro cap | −40.40% |
| 7096.T | StemCell Institute Inc. | $45.44M | Micro cap | −17.13% |
| 3750.T | ADR Biomedical Holdings Inc. | $42.72M | Micro cap | −12.00% |
| DTSQ | DT Cloud Star Acquisition Corporation | $42.31M | Micro cap | +9.27% |
| ALA.AX | Arovella Therapeutics Limited | $41.58M | Micro cap | −44.32% |
| CCEL | Cryo-Cell International, Inc. | $40.39M | Micro cap | +9.63% |
| ESLA | Estrella Immunopharma, Inc. | $39.97M | Micro cap | −59.70% |
| 2370.T | MEDINET Co., Ltd. | $39.33M | Micro cap | −37.14% |
| 4880.T | CellSource Co., Ltd. | $38.80M | Micro cap | −39.44% |
| ACET | Adicet Bio, Inc. | $36.88M | Micro cap | −72.70% |
| 4892.T | Cyfuse Biomedical K.K. | $36.19M | Micro cap | −5.64% |
| SVA.TO | Sernova Biotherapeutics Inc | $29.67M | Micro cap | −31.25% |
| 4893.T | Noile-Immune Biotech Inc. | $23.96M | Micro cap | −46.01% |
| NCEL | NewcelX Ltd. | $14.73M | Micro cap | −79.44% |
| PLUR | Pluri Inc. | $14.12M | Micro cap | −71.28% |
| BCDA | BioCardia, Inc. | $13.65M | Micro cap | −31.18% |
| TCRX | TScan Therapeutics, Inc. | $12.40M | Micro cap | −91.68% |
| GDTC | CytoMed Therapeutics Limited | $11.05M | Micro cap | −61.73% |
| INAB | IN8bio, Inc. | $9.52M | Micro cap | −54.02% |
| CMB.AX | Cambium Bio Limited | $8.68M | Micro cap | −13.40% |
| 1AD.AX | AdAlta Limited | $6.76M | Micro cap | −25.00% |
| FBLG | FibroBiologics, Inc. | $6.66M | Micro cap | −89.15% |
| SNTI | Senti Biosciences Holdings, Inc. | $5.87M | Micro cap | −92.18% |
| CELZ | Creative Medical Technology Holdings, Inc. | $5.41M | Micro cap | −86.16% |
| LGVN | Longeveron Inc. | $5.12M | Micro cap | +75.03% |
| 0QFK.L | Celyad Oncology SA | $4.54M | Micro cap | −8.85% |
| PMCB | PharmaCyte Biotech, Inc. | $3.76M | Micro cap | −64.53% |
| ERNA | Ernexa Therapeutics Inc. | $3.37M | Micro cap | −93.49% |
| MBIO | Mustang Bio, Inc. | $2.73M | Micro cap | −75.99% |
| BRTX | BioRestorative Therapies, Inc. | $2.18M | Micro cap | −0.63% |
| CYP.AX | Cynata Therapeutics Limited | $1.88M | Micro cap | −96.14% |
| CHM.AX | Chimeric Therapeutics Limited | $311.03K | Micro cap | −99.00% |
| ALCLS.PA | Cellectis S.A. | — | Small cap | −70.45% |
| BSFA.L | BSF Enterprise Plc | — | — | −66.94% |
| CRBU | Caribou Biosciences, Inc. | — | — | −79.91% |
| DTSQU | DT Cloud Star Acquisition Corporation | — | Small cap | +10.85% |
| PTG.WA | Poltreg S.A. | — | Small cap | −27.11% |
| SYNC.L | Syncona Limited | — | Small cap | +29.90% |
| V3V.DE | FamiCord AG | — | — | −51.62% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 79 companies grouped under the Cell therapy theme. The median market value in the group is $55.46M. Among the 47 with a price from the latest session, the median move over the past trading day is −1.38%. 22% of the 78 with a 200-day average trade above it. Price change over the past year runs from −81.3% to +33.6% across the middle 80 percent of the group, with a median of −36.5%.